Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Zeenia Jagga
    Junior Member
    • Jan 2016
    • 1

    #1

    Differential expression gene list from TCGA level 3 RNASeq V2 datasets downloaded fro

    I am interested in calculating differential expression of genes for tumor vs. normal samples from RNASeq V2 level 3 datasets for TCGA (downloaded from UCSC Cancer Browser). This data is from *.rsem.genes.normalized_results, log2(x+1) transformed and upper quantile normalized

    After browsing a lot of literature, blogs and forums, I am able to note following methods of calculate differential expression from TCGA datasets.

    1. Fold change Since the values from UCSC are already log 2 transformed, for a gene x, of tumor y, Log 2 fold change can be calculated as (log 2 transformed gene expression value of tumor sample) - (log 2 transformed gene expression value of matched normal sample).

    2. Packages like limma to fit a linear model to the log2-transformed data using an empirical Bayes method to moderate standard errors.

    3. Package EBSeq, as RSEM’s original paper since that algorithm takes into account the stochastic nature of the RSEM output.

    4. Or, I should get expected_counts or scaled-estimates from TCGA data-portal and then use voom() to normalize, as well as packages like DESeq, EBSeq, limma for differential expression

    5. Z-score (if comparing tumor vs. normal) = [(value gene X in tumor Y) - (mean gene X in normal)] / (standard deviation of gene X in normal)

    I also see variation of Z-score application as

    (A) in the TCGA cases where tumor samples are more than normal like say 500 tumor samples out of which only 65 have matched normal sample

    (B) In TCGA cases where you have only tumor samples or you want to consider only tumor samples and you can compare it with data of normal tissues as from GTEx

    (C) In cases where you have only tumor samples and twisting the calculations as

    Z-score= [(gene x log value – mean of log values gene x for all tumor tissues)/ standard deviation of gene x from mean of all tumor tissues]

    I would appreciate if fellow members can comment or suggest or share there experiences on dealing with such kind of datasets, on the following lines:

    Query 1: Have I understood these methods correct? How else we can calculate differential from TCGA datasets?

    Query 2. Since, Z-score assumes normal distribution and for RNASeq expression values one would not expect normal distribution, one should go for quantile normalization, but as TCGA datasets in UCSC is already quantile normalized, should these values be used directly and simply calculate fold change with that.

    Query 3. Are all the variations of Z-score mentioned in point 5 valid?

    Query 4: Which of the above or any other method is the most recommended method to calculate differential expression for tumor vs. normal samples from TCGA datasets and why?

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...